191 related articles for article (PubMed ID: 1390701)
21. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
Salhany JM; Sloan RL; Cordes KS
Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
[TBL] [Abstract][Full Text] [Related]
22. Random chemical modification of the oxygen-linked chloride-binding sites of hemoglobin: those in the central dyad axis may influence the transition between deoxy- and oxy-hemoglobin.
Ueno H; Popowicz AM; Manning JM
J Protein Chem; 1993 Oct; 12(5):561-70. PubMed ID: 8141998
[TBL] [Abstract][Full Text] [Related]
23. Allosteric kinetics and equilibria of triligated, cross-linked hemoglobin.
Zhao M; Jiang J; Greene M; Andracki ME; Fowler SA; Walder JA; Ferrone FA
Biophys J; 1993 May; 64(5):1520-32. PubMed ID: 8324188
[TBL] [Abstract][Full Text] [Related]
24. Red cell anion channel blockade: extracellular modulation of internal membrane function.
Eaton JW; Tsai MY; Leida MN; Branda R
Prog Clin Biol Res; 1981; 55():409-22. PubMed ID: 6270695
[No Abstract] [Full Text] [Related]
25. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
Omar AM; Mahran MA; Ghatge MS; Bamane FH; Ahmed MH; El-Araby ME; Abdulmalik O; Safo MK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529207
[TBL] [Abstract][Full Text] [Related]
26. The rationale for, and effects of oxygen delivery enhancement to ischemic brain in a feline model of human stroke.
Doppenberg EM; Watson JC; Bullock R; Gerber MJ; Zauner A; Abraham DJ
Ann N Y Acad Sci; 1997 Oct; 825():241-57. PubMed ID: 9369991
[TBL] [Abstract][Full Text] [Related]
27. Effect of RSR13 on temperature-dependent changes in hemoglobin oxygen affinity of human whole blood.
Steffen RP
Adv Exp Med Biol; 1998; 454():653-61. PubMed ID: 9889946
[No Abstract] [Full Text] [Related]
28. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Teicher BA; Wong JS; Takeuchi H; Gravelin LM; Ara G; Buxton D
Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of residual chloride transport in human red blood cells after maximum covalent 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid binding.
Gasbjerg PK; Funder J; Brahm J
J Gen Physiol; 1993 May; 101(5):715-32. PubMed ID: 8393066
[TBL] [Abstract][Full Text] [Related]
30. pH-dependence of inhibition by H2DIDS of mouse erythroid band 3-mediated Cl- transport in Xenopus oocytes. The effect of oligonucleotide-directed replacement of Lys-558 by an Asn residue.
Kietz D; Bartel D; Lepke S; Passow H
Biochim Biophys Acta; 1991 Apr; 1064(1):81-8. PubMed ID: 1902748
[TBL] [Abstract][Full Text] [Related]
31. Allosteric effectors do not alter the oxygen affinity of hemoglobin crystals.
Mozzarelli A; Rivetti C; Rossi GL; Eaton WA; Henry ER
Protein Sci; 1997 Feb; 6(2):484-9. PubMed ID: 9041656
[TBL] [Abstract][Full Text] [Related]
32. Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions.
Low PS
Biochim Biophys Acta; 1986 Sep; 864(2):145-67. PubMed ID: 2943319
[No Abstract] [Full Text] [Related]
33. Allosteric kinetics and equilibria differ for carbon monoxide and oxygen binding to hemoglobin.
Zhang NQ; Ferrone FA; Martino AJ
Biophys J; 1990 Aug; 58(2):333-40. PubMed ID: 2207241
[TBL] [Abstract][Full Text] [Related]
34. The anion-transport inhibitor H2DIDS cross-links hemoglobin interdimerically and enhances oxygen unloading.
Fuhrmann GF; Kreutzfeldt C; Rudolphi K; Fasold H
Biochim Biophys Acta; 1988 Dec; 946(1):25-32. PubMed ID: 3207730
[TBL] [Abstract][Full Text] [Related]
35. Light-scattering measurements of hemoglobin binding to the erythrocyte membrane. Evidence for transmembrane effects related to a disulfonic stilbene binding to band 3.
Salhany JM; Cordes KA; Gaines ED
Biochemistry; 1980 Apr; 19(7):1447-54. PubMed ID: 7388003
[No Abstract] [Full Text] [Related]
36. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
Kilgore KS; Shwartz CF; Gallagher MA; Steffen RP; Mosca RS; Bolling SF
Circulation; 1999 Nov; 100(19 Suppl):II351-6. PubMed ID: 10567328
[TBL] [Abstract][Full Text] [Related]
37. Interactions of drugs and folate compounds at the cellular level.
Branda RF; Nelson NL
Prog Clin Biol Res; 1981; 77():773-81. PubMed ID: 7335712
[No Abstract] [Full Text] [Related]
38. Synthesis and X-ray studies of chiral allosteric modifiers of hemoglobin.
Youssef AM; Safo MK; Danso-Danquah R; Joshi GS; Kister J; Marden MC; Abraham DJ
J Med Chem; 2002 Mar; 45(6):1184-95. PubMed ID: 11881987
[TBL] [Abstract][Full Text] [Related]
39. Effect of DIDS on osmotic properties of bovine erythrocytes.
Mosior M; Białas WA; Gomułkiewicz J
Biochim Biophys Acta; 1988 Nov; 945(1):51-5. PubMed ID: 3179310
[TBL] [Abstract][Full Text] [Related]
40. Reversible and irreversible inhibition, by stilbenedisulphonates, of lactate transport into rat erythrocytes. Identification of some new high-affinity inhibitors.
Poole RC; Halestrap AP
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):307-12. PubMed ID: 2025218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
